Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland

Recruiting Observational Study
Takotsubo Cardiomyopathy Myocardial Infarction
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
800 (estimated)
Sponsor
University of Aberdeen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Acute stress-induced (Takotsubo cardiomyopathy) presents like a heart attack and is triggered by intense emotional or physical stress. Although coronary arteries are unobstructed, it has been suggested that the risk of death is similar to a myocardial infarction. The purpose of the STARR study is to identify all cases of Takotsubo in Scotland since 2010 and assess its epidemiology and outcomes.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients diagnosed with Takotsubo cardiomyopathy Exclusion Criteria: * NA
Contacts

Dana Dawson, MD, MRCP

01224 437969

dana.dawson@abdn.ac.uk

CONTACT

Amelia Rudd, HND

01224 559573

a.e.rudd@abdn.ac.uk

CONTACT